Q2 Earnings Blowouts: 37 Stocks That Beat Expectations
The ongoing earnings season has been a boon to listed companies' share prices in the second quarter of the year, helping offset macroeconomic uncertainties such as the US-Iran...
Posts Tagged ‘BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’
10 Most Promising Stocks with Highest Upside Potential
On June 16, Savita Subramanian, BofA Securities, joined CNBC's 'Power Lunch' to discuss the overall market environment and whether earnings momentum can continue.
10 Most Undervalued Stocks to Buy and Hold for 2 Years
On May 27, Kathleen Entwistle, Managing Director & Private Wealth Advisor at Morgan Stanley Private Wealth Management, joined CNBC's 'Fast Money' to discuss buying opportunities...
8 Stocks That Could 10X by 2030
Could rising bond yields, along with economic and inflationary pressures, be spelling trouble or a correction for the equity market? That’s the big question at a time when equities...
10 Best Low Priced Stocks to Buy for the Next 3 Years
On May 12, Chris Veronne of Strategas appeared on CNBC's 'Closing Bell Overtime' to share his technical take on the current market picture.
Evercore ISI Lifts PT on BioMarin Pharmaceutical Inc. (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best healthcare stocks to buy for the long term. Evercore ISI lifted the price target on BioMarin Pharmaceutical Inc.
10 Best Healthcare Stocks to Buy for the Long Term
On May 7, Haig Bathgate, CEO of Callanish Capital, appeared on CNCB to talk about his bullish view on the global markets amid the Iran war, and how its impact would be short-lived...
Is BioMarin Pharmaceutical Inc. (BMRN) One of the Top Cheap Stocks to Buy With the Biggest Upside Potential?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the top cheap stocks to buy with the biggest upside potential. BioMarin Pharmaceutical Inc.
Top 10 Cheap Stocks to Buy with Biggest Upside Potential
He was of the view that the risk/reward for stocks is still pretty good.
BioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase 2 Study Discontinuations
We recently compiled a list of the 10 Quality Value Stocks Likely to Make a Comeback According to Analysts. BioMarin Pharmaceutical Inc.
10 Best Stocks That Recently Issued New Debt
In this article, we will look at the best stocks that recently issued new debt and currently offer attractive upside potential for investors.
10 Quality Value Stocks Likely to Make a Comeback According to Analysts
Fidelity portfolio managers believe that predicting which stocks will lead in the coming year remains difficult, especially as market uncertainty continues to dominate investor...
10 Cheap Stocks to Buy for High Returns in 2026
On March 16, Mike Wilson from Morgan Stanley appeared on a CNBC Television interview to discuss the latest market trends and the impact of the Iran war.
BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ in Adolescents
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best get-rich-quick stocks to buy according to hedge funds.
12 Best Get Rich Quick Stocks to Buy According to Hedge Funds
On March 9, Main Management CEO and Portfolio Manager Kim Arthur joined CNBC’s ‘Halftime Report’ to talk about what he’s seeing in his sector rotation fund, and whether...
Canaccord Lifts PT on BioMarin Pharmaceutical (BMRN) to $104 From $98 – Here’s Why
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best cheap biotech stocks to buy now. Canaccord lifted the price target on BioMarin Pharmaceutical Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here’s Why
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the top gene therapy stocks to buy according to hedge funds.
Top 10 Gene Therapy Stocks to Buy According to Hedge Funds
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
BioMarin Pharmaceutical Inc. (BMRN) Seen as Attractive Buy Ahead of Transcon-CNP PDUFA, Says Wells Fargo
TheFly reported on February 18 that Wells Fargo & Company increased its price target for BMRN from $70 to $75 while keeping an Overweight rating.
20 Best Investments in 2026
The S&P 500 reached a new high as investors focused on upcoming tech sector earnings, and U.S.
What Does the Street Think About BioMarin Pharmaceutical Inc. (BMRN)?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most promising future stocks to buy now. Piper Sandler revised the price target on BioMarin Pharmaceutical Inc.
13 Most Promising Future Stocks to Buy Now
On February 6, Josh Belton, Gabelli Funds portfolio manager for growth equities, appeared on CNBC’s 'Squawk Box' to talk about the latest market trends, his perspective on where...
Acquisition Plans to Fuel BioMarin Pharmaceutical (BMRN), According to Barclays
Barclays initiated coverage of BioMarin on January 28, assigning it an “Overweight” rating and a target price of $80.
12 Best Cheap Stocks to Buy Right Now
Kevin Warsh, Donald Trump’s pick to be the next chair of the Federal Reserve, could be good news for the stock market, at least in the near term.
H.C. Wainwright: BioMarin’s (BMRN) Amicus Acquisition Stabilizes Cash Flow While Voxzogo Remains Near-Term Driver
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best NASDAQ stocks to buy in 2026. On December 22, H.C.
12 Best NASDAQ Stocks to Buy in 2026
On December 30, Victoria Fernandez, Crossmark Chief Market Strategist, joined 'Closing Bell' on CNBC to discuss investment strategies for the technology sector as we head into...
Is BioMarin Pharmaceutical Inc. (BMRN) the Ridiculously Cheap Stock to Buy Now?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the ridiculously cheap stocks to buy now. As of December 26, BioMarin Pharmaceutical Inc.
13 Ridiculously Cheap Stocks to Buy Now
Markets are hardly rational, and that’s what makes things so interesting.
7 Most Promising Gene Editing Stocks According to Analysts
Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, delete, or modify DNA within living cells.
BioMarin (BMRN) Jumps 17.7% on $5-Billion Merger with Amicus
BioMarin Pharmaceutical extended its winning streak to a third straight day on Friday, surging 17.71 percent to finish at $61.15 apiece, as investors took heart from its expansion...
Leerink Cuts BioMarin Pharmaceutical Inc. (BMRN) Price Target to $60, Citing Valuation and Competitive Challenges
Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks to buy according to Wall Street analysts.
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
BioMarin Pharmaceutical Inc. (BMRN) Outlook Lowered By Leerink
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the cheap healthcare stocks to buy heading into 2026.
12 Cheap Healthcare Stocks to Buy Heading into 2026
Since the pandemic, healthcare is one of the sectors that have remained in the spotlight even amid market twists.
J.P. Morgan Reiterates a Buy Rating on BioMarin Pharmaceutical (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best stocks to buy with over 50% upside potential. BioMarin Pharmaceutical Inc.
10 Stocks to Buy With Over 50% Upside Potential
He stated that the market has begun to exhibit signs of increased speculation.
10 Best Beaten Down Growth Stocks to Buy According to Analysts
On October 27, Tejas Dessai, Director of Research at Global X ETFs, joined CNBC Television for an interview to discuss how the big tech earnings this week are expected to impact...
BioMarin Pharmaceutical (BMRN) Announces Financial Results for Q3 2025
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Stocks to Buy with Exponential Growth Heading into 2026.
13 Stocks to Buy with Exponential Growth Heading into 2026
As per Fidelity, the tax law that was passed over the summer is projected to reduce the effective corporate tax rate.
Why is BioMarin Pharmaceutical (BMRN) One of the Most Profitable Biotech Stocks to Buy?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy rating on BioMarin Pharmaceutical Inc.
9 Most Profitable Biotech Stocks to Buy
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
Cantor Fitzgerald Reiterates a Buy Rating for BioMarin Pharmaceutical (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best healthcare stocks with the highest upside.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
Where is BioMarin Pharmaceutical (BMRN) Headed According to Analysts?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks with high potential. BioMarin Pharmaceutical Inc.
14 Biotech Stocks with High Potential
On October 1, Evan Seigerman, head of healthcare research at BMO Capital Markets, appeared on CNBC’s “The Exchange” to talk about what the future may be like for healthcare...
Growth and Pipeline Keep BioMarin Pharmaceutical Inc. (BMRN) Attractive for Investors
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the most promising biotech stocks to buy according to hedge funds. In the second quarter, Tealwood Asset Management Inc.
BioMarin Pharmaceutical Inc. (BMRN) Hits Its 52-Week Low
On September 23, 2025, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) hit a 52-week low, falling 23.7% over the past year to $52.93.
7 Most Promising Biotech Stocks to Buy According to Hedge Funds
If there’s one sector that is gaining popularity each day, it’s definitely the biotechnology market.
Raymond James Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a $85 PT
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best strong buy stocks to invest in according to Wall Street.
Hedge Fund Resource Center
